Vicari A - Search Results

1

Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.

Laugel B, Borlat F, Galibert L, Vicari A, Weissert R, Chvatchko Y, Bruniquel D. Laugel B, et al. Among authors: vicari a. J Neuroimmunol. 2011 Dec 15;240-241:52-7. doi: 10.1016/j.jneuroim.2011.09.010. Epub 2011 Oct 26. J Neuroimmunol. 2011. PMID: 22035961

2

Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.

Goffin L, Fagagnini S, Vicari A, Mamie C, Melhem H, Weder B, Lutz C, Lang S, Scharl M, Rogler G, Chvatchko Y, Hausmann M. Goffin L, et al. Among authors: vicari a. Inflamm Bowel Dis. 2016 Sep;22(9):2041-57. doi: 10.1097/MIB.0000000000000863. Inflamm Bowel Dis. 2016. PMID: 27542125

3

Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.

Vicari AP, Schoepfer AM, Meresse B, Goffin L, Léger O, Josserand S, Guégan N, Yousefi S, Straumann A, Cerf-Bensussan N, Simon HU, Chvatchko Y. Vicari AP, et al. MAbs. 2017 Aug/Sep;9(6):927-944. doi: 10.1080/19420862.2017.1332553. Epub 2017 Jun 5. MAbs. 2017. PMID: 28581883 Free PMC article.

4

Multiple effects caused by anti-IL-4 mAb inoculation in the thymus and spleen of adult mice.

Vicari A, Papiernik M. Vicari A, et al. Eur Cytokine Netw. 1993 Mar-Apr;4(2):111-9. Eur Cytokine Netw. 1993. PMID: 8318671

5

MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.

Leite-de-Moraes MC, Herbelin A, Machavoine F, Vicari A, Gombert JM, Papiernik M, Dy M. Leite-de-Moraes MC, et al. Among authors: vicari a. J Immunol. 1995 Nov 15;155(10):4544-50. J Immunol. 1995. PMID: 7594451

6

Chemokines in cancer.

Vicari AP, Caux C. Vicari AP, et al. Cytokine Growth Factor Rev. 2002 Apr;13(2):143-54. doi: 10.1016/s1359-6101(01)00033-8. Cytokine Growth Factor Rev. 2002. PMID: 11900990 Review.

7

Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine thymocytes positively selected by class I molecules.

Vicari A, de Moraes Mdo C, Gombert JM, Dy M, Penit C, Papiernik M, Herbelin A. Vicari A, et al. J Exp Med. 1994 Aug 1;180(2):653-61. doi: 10.1084/jem.180.2.653. J Exp Med. 1994. PMID: 8046338 Free PMC article.

8

Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses.

Dercamp C, Chemin K, Caux C, Trinchieri G, Vicari AP. Dercamp C, et al. Cancer Res. 2005 Sep 15;65(18):8479-86. doi: 10.1158/0008-5472.CAN-05-1319. Cancer Res. 2005. PMID: 16166328

9

MTS-32 monoclonal antibody defines CD4+8- thymocyte subsets that differ in their maturation level, lymphokine secretion, and selection patterns.

Vicari A, Abehsira-Amar O, Papiernik M, Boyd RL, Tucek CL. Vicari A, et al. J Immunol. 1994 Mar 1;152(5):2207-13. J Immunol. 1994. PMID: 7907634

10

Endogenous granulocyte-macrophage colony-stimulating factor is involved in IL-1- and IL-7-induced murine thymocyte proliferation.

Herbelin A, Machavoine F, Vicari A, Schneider E, Papiernik M, Ziltener H, Penit C, Dy M. Herbelin A, et al. Among authors: vicari a. J Immunol. 1994 Sep 1;153(5):1973-81. J Immunol. 1994. PMID: 8051402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page